Oxford, UK, October 18th,  2012

PharmaVentures today announced the appointment of Stephen Waterman as Vice President in its Corporate Advisory business, significantly enhancing PharmaVentures’ corporate finance capabilities and offerings to the global healthcare and investment communities.

Fintan Walton, PhD, PharmaVentures’ Chief Executive Officer says “We are delighted to welcome Stephen to PharmaVentures. Stephen has an impressive track record in investment banking and he brings a wealth of experience in private and public markets that will assist our clients with their deal making and Stephen’s addition to PharmaVentures will therefore be of great benefit.”

Stephen has previously worked with WG Partners, Matrix Corporate Capital, Elixir Securities, Commerzbank, Teather & Greenwood and Evaluate Pharma Plc. He has a BSc from Nottingham University and PhD from Cambridge University.

– ends –